[mo_oauth_login]
Summary report
NORDWISE BIOTECH OÜ
Date of report 04.06.2025
NORDWISE BIOTECH OÜ
14877534 -
Registered
Founded in
30.12.2019
Fixed capital
100,000 €
VAT
EE102244599
(start 01.04.2020)
| start | end |
|---|---|
| 01.04.2020 | - |
keywords
- teadustegevus tehnoloogias
NORDWISE BIOTECH OÜ
Scores and ratings
Reputation score
1910
What is Reputation score?
Credit Score
Trustworthy
0.01
Credit score today
Trustworthy
0.01
2019
year
Open the reports you want to print
Employees and salaries
NORDWISE BIOTECH OÜ
Number of employees and estimated average salaries?
| 2024 II | 2024 III | 2024 IV | 2025 I | |
| Number of employees | ...... | ...... | ...... | ...... |
| Average gross salary | ...... | ...... | ...... | ...... |
NORDWISE BIOTECH OÜ
Employee taxes and performance analysis?
| Quarter | Labor taxes paid | Number of employees | Turnover Per Employee | Profit per employee |
|---|---|---|---|---|
| 2025 I | ...... | ...... | ...... | ...... |
| 2024 IV | ...... | ...... | ...... | ...... |
| 2024 III | ...... | ...... | ...... | ...... |
| 2024 II | ...... | ...... | ...... | ...... |
| 2024 I | ...... | ...... | ...... | ...... |
| 2023 IV | ...... | ...... | ...... | ...... |
| 2023 III | ...... | ...... | ...... | ...... |
| 2023 II | ...... | ...... | ...... | ...... |
| 2023 I | ...... | ...... | ...... | ...... |
| 2022 IV | ...... | ...... | ...... | ...... |
| 2022 III | ...... | ...... | ...... | ...... |
| 2022 II | ...... | ...... | ...... | ...... |
| 2022 I | ...... | ...... | ...... | ...... |
| 2021 IV | ...... | ...... | ...... | ...... |
| 2021 III | ...... | ...... | ...... | ...... |
| 2021 II | ...... | ...... | ...... | ...... |
| 2021 I | ...... | ...... | ...... | ...... |
| 2020 IV | ...... | ...... | ...... | ...... |
| 2020 III | ...... | ...... | ...... | ...... |
| 2020 II | ...... | ...... | ...... | ...... |
| 2020 I | ...... | ...... | ...... | ...... |
| 2019 IV | ...... | ...... | ...... | ...... |
Deciders and beneficiaries
NORDWISE BIOTECH OÜ
Decision-makers?
Former decision-makers
Relations:
3
Turnover 2025:
620 819 €
Employees:
30
Ene Tammsaar
★★★★
......
Credit Score: Trustworthy
Reputation score: 4700
Date of birth: ......
Active relations 3
10 followers
*Every member of the management board may represent the private limited company in concluding all transactions.
NORDWISE BIOTECH OÜ
Former decision-makers?
Relations:
3
Turnover 2025:
620 819 €
Employees:
30
Ene Tammsaar
★★★★
......
Credit Score: Trustworthy
Reputation score: 4700
Date of birth: ......
Active relations 3
10 followers
Relations:
2
Turnover 2025:
5 588 €
Employees:
2
TIIT SUUDER
★★★★
......
Credit Score: Trustworthy
Reputation score: 870
Date of birth: ......
Active relations 2
12 followers
NORDWISE BIOTECH OÜ
History of right of representation?
Field
Administrative Activities
Business age
5y
Beneficial country:
Estonia
2019
2020
2021
2022
2023
2024
2025
2019
2020
2021
2022
2023
2024
2025
NORDWISE BIOTECH OÜ
Owners?
Former owners
NORDWISE BIOTECH OÜ
Other related parties?
Former other persons
Beneficiaries
Volumes and values of beneficiaries' assets
Net asset value of the beneficiary
... €
Value of beneficiary companies using the income method
... €
Analytically identified company holdings and asset volumes
Net asset value of the beneficiary
... €
Value of beneficiary companies using the income method
... €
Analytically identified company holdings and asset volumes
Net asset value of the beneficiary
... €
Value of beneficiary companies using the income method
... €
Analytically identified company holdings and asset volumes
Finances and assets
NORDWISE BIOTECH OÜ
Goodwill| EUR | 2023 | 2024 | 2025 | Trend |
| Goodwill | ...... | ...... | ...... | |
| Goodwill | ...... | ...... | ...... |
NORDWISE BIOTECH OÜ
Taxes paid and estimated average salaries| 2022 | 2023 | 2024 | 2025 | |
| National taxes | ...... | ...... | ...... | ...... |
| Labor taxes | ...... | ...... | ...... | ...... |
| Average gross salary | ...... | ...... | ...... | ...... |
NORDWISE BIOTECH OÜ
Quarterly indicators| Quarter | Turnover | Taxed turnover | Labour productivity | Labour productivity | Employees | National taxes | Labor taxes |
|---|---|---|---|---|---|---|---|
| 2025 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
NORDWISE BIOTECH OÜ
Sales revenue by business arearevenue
| Field of activity | EMTAK code | Sales revenue (2023) | Sales revenue % |
| Online shop | - | - | |
| Research activities in biotechnology | 72111 | 127 238 € | 100,00 |
NORDWISE BIOTECH OÜ
Sales revenue by country| Turnover EUR | 2023 | 2024 prognosis | 2025 prognosis | Trend |
| Total sales | ...... | ...... | ...... | |
| Estonia | ...... | ...... | ...... | |
| Germany | ...... | ...... | ...... | |
| Leed | ...... | ...... | ...... | |
| Other EU countries | ...... | ...... | ...... | |
| United States of America | ...... | ...... | ...... | |
| Total exports | ...... | ...... | ...... |
NORDWISE BIOTECH OÜ
Financial indicators and prognosis| Financial indicators | 2023 | 2024 Prognosis | 2025 Prognosis |
Trend |
| TURNOVER | ...... | ...... | ...... | |
| Estonia | ...... | ...... | ...... | |
| Other countries | ...... | ...... | ...... | |
| INTEREST INCOME | ...... | ...... | ...... | |
| OTHER BUSINESS INCOME | ...... | ...... | ...... | |
| TURNOVER IN RELATED COMPANY | ...... | ...... | ...... | |
| AVERAGE MONTHLY TURNOVER | ...... | ...... | ...... | |
| Available credit (credit limit) | ...... | ...... | ...... | |
| Settlement dates | ...... | ...... | ...... | |
| RECEIVED GRANTS € | ...... | ...... | ...... | |
| TENDERS WON € | ...... | ...... | ...... | |
| ASSETS | ...... | ...... | ...... | |
| Current assets | ...... | ...... | ...... | |
| Fixed assets | ...... | ...... | ...... | |
| LIABILITIES | ...... | ...... | ...... | |
| Short-term liabilities | ...... | ...... | ...... | |
| Long-term liabilities | ...... | ...... | ...... | |
| EQUITY | ...... | ...... | ...... | |
| Share-(equity capital) | ...... | ...... | ...... | |
| Retained profits | ...... | ...... | ...... | |
| Net profit | ...... | ...... | ...... | |
| NET WORKING CAPITAL | ...... | ...... | ...... | |
| NUMBER OF EMPLOYEES | ...... | ...... | ...... |
NORDWISE BIOTECH OÜ
Financial raiting: "SATISFACTORY" (2025 prognosis)| Multipliers and income levels | 2024 prognosis | 2025 prognosis |
Trend |
| LIQUIDITY | ...... | ...... | |
| Net Working capital | ...... | ...... | |
| Short-term debt coverage ratio (X) | ...... | ...... | |
| EFFECTIVENESS | ...... | ...... | |
| Debt to assets ratio (X) | ...... | ...... | |
| Capitalisation multiplier (X) | ...... | ...... | |
| USE OF LOAN CAPITAL | ...... | ...... | |
| Turnover ratio of fixed assets (X) | ...... | ...... | |
| PROFITABILITY | ...... | ...... | |
| Sales revenues (%) | ...... | ...... | |
| Total asset revenues (%) | ...... | ...... | |
| Equity revenues (%) | ...... | ...... |
2025 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good
NORDWISE BIOTECH OÜ
Annual reportsLiabilities and debts
NORDWISE BIOTECH OÜ
Credit score history and prognosisRecommended credit limit
... €
Recommended payment term
......
Business risk classes:
Trustworthy Neutral
Borderline
Problematic
Risky
NORDWISE BIOTECH OÜ
Reports and assets-liabilities overview 04.06.2025?
Annual reports:
......
Annual reports: ......
Tax declarations:......
Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €
NORDWISE BIOTECH OÜ
Claims history?
1 month
6 months
Year
5 years
MAX
1 month
6 months
Year
5 years
MAX
Debt claims as of ......
Total debt claims: ...... €
Latest events
| ...... | ...... |
NORDWISE BIOTECH OÜ
Income (turnover) and expenditure (taxes paid)?
| Quarter | Turnover | Taxed turnover | National taxes paid | Labor taxes paid | Number of employees |
|---|---|---|---|---|---|
| 2025 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 I | * ...... € | ...... € | ...... € | ...... € | ...... |
NORDWISE BIOTECH OÜ
Bailiff's enforcement proceedings as of 04.06.2025?
Bailiff's enforcement proceedings MISSING
NORDWISE BIOTECH OÜ
Regulations of the Payment Order Department as of 04.06.2025?
Regulations of the Payment Order Department MISSING
NORDWISE BIOTECH OÜ
Court orders in the register as of 04.06.2025?
Puuduste kõrvaldamise määrus kandeväliste andmete parandamiseks
04.03.2025
Regulation number: Ä 50136183 / M1
Regulation status has entered into force: 09.03.2025
Date of enforcement of order or additional period: 04.03.2025
Regulation status: Puudused kõrvaldatud
NORDWISE BIOTECH OÜ
Decisions of the Consumer Disputes Committee as of 04.06.2025?
Consumer disputes MISSING
NORDWISE BIOTECH OÜ
Court hearings as of 04.06.2025?
Court hearings MISSING
NORDWISE BIOTECH OÜ
Rulings as of 04.06.2025?
Kohtuotsus tsiviilasjas nr 2-24-116823/20
Tartu Maakohus Tartu kohtumaja
11.04.2025
| Related companies: | |
| Number of the case: | 2-24-116823/20 |
| Type of procedure: | Tsiviilasi |
| Court: | Tartu Maakohus Tartu kohtumaja |
| Type of solution: | Kohtuotsus |
| Solution subcategory: | - |
| Composition of the Court: | Külli Puusep |
| Commencement of the Court case: | 06.06.2024 |
| Type of procedure: | Kohtu I astme menetlus |
| Commencement of proceedings: | 06.06.2024 |
| Court case category: | Võlaõigus |
| Keyword: | - |
| Court decision date: | 11.04.2025 |
| Entry into force: | 13.05.2025 |
| Dissenting opinion: | |
| ECLI identifier: ? |
ECLI:EE:TMK:2025:2.24.116823.6118 |
NORDWISE BIOTECH OÜ
Notices and announcements as of 04.06.2025?
Announcements MISSING
Marketing
Business network
NORDWISE BIOTECH OÜ
Business networkCREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired
Sign in
To expand your connections, log in to the "Networks" environment
Beneficiaries network
NORDWISE BIOTECH OÜ
Networks - Beneficiaries
The network is visible with reduced links
Expand threads if desired
Sign in
To expand your connections, log in to the "Networks" environment
Monitoring events
Filter
Dropdown
Dropdown
Neutral
Positive
Negative
No monitoring events found.
Failed to load monitoring events.